You may also like
Bridging Anti Platelet Therapy in Patients Requiring Cardiac and Non-Cardiac Surgery: From Bench to Bedside
This article explores the theoretical background and rationale for bridging patients on antiplatelet drugs to their surgical procedure, and provides insights on how patient and procedural characteristics translate into different considerations for the use of antithrombotic agents in the surgical setting.
1 min read
Thrombelastography Change after Bridging to Left Ventricular Assist Device from Extracorporeal Membrane Oxygenation Patients
The cause of coagulopathy is seldom reported; therefore, the current prospective study was designed to compare the coagulation status between patients who received extracorporeal membrane oxygenation (ECMO) and bridged ventricular assist device (VAD) thereafter.
1 min read
Levosimendan in Veno-Arterial Extracorporeal Membrane Oxygenator Supported Patients: Impact on the Success of Weaning and Survival
Levosimendan can be safely administered during VA‐ECMO support. Patients receiving levosimendan were weaned similarly from circulatory support despite worse LVEF. Its use did not influence in short and medium term survival.
1 min read